MK0493

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Obesity

Phase 2

To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)

CompletedNCT00482196

Merck Sharp & Dohme LLCObesity

Start: 2005-07-31End: 2006-03-31Updated: 2015-04-28

Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)

CompletedNCT00482638

Merck Sharp & Dohme LLCObesity

Start: 2004-05-12End: 2004-10-29Updated: 2019-11-14